Planning Split-Apheresis Designs for Demonstrating Comparability of Cellular and Gene Therapy Products
Crossref DOI link: https://doi.org/10.1208/s12248-024-00977-9
Published Online: 2024-09-16
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Burdick, Richard https://orcid.org/0009-0002-5212-1819
Hofer, Jeff
Karl, Andrew
Rushing, Heath
Text and Data Mining valid from 2024-09-16
Version of Record valid from 2024-09-16
Article History
Received: 11 June 2024
Accepted: 5 September 2024
First Online: 16 September 2024
Declarations
:
: The authors declare they have no competing interest.